In a historic move that demonstrated its dedication to healthcare and social responsibility, Supriya Lifescience Ltd. partnered with seven of Mumbai’s top blood banks to conduct a massive blood drive. 525 blood units were collected in a single day thanks to the remarkable attendance for the drive, which saw 1,790 donors come forward to support the cause.
Prabodhan Bloodbank, Nair Hospital, Sion Hospital, KEM Hospital, Wadia Hospital, Breach Candy Hospital Trust, and Jaslok Hospital & Research Centre worked together to carry out the project. Volunteers and donors from a variety of backgrounds participated in the camp, which started at Prabodhan Bloodbank at 7 a.m., all of whom were motivated to make a significant difference.
“This blood drive is a testament to the power of community and shared purpose,” stated Dr. Satish Wagh, Executive Chairman and Whole-time Director of Supriya Lifescience Ltd., in a statement marking the event. We at Supriya Lifescience are motivated by the conviction that every endeavor, no matter how minor, has the potential to improve our healthcare system and save lives. The generosity of everyone who came forward today has moved me to tears. Without a doubt, their donations will have an impact where it is most needed.
Supriya Lifescience Ltd.’s steadfast commitment to meeting urgent healthcare needs and promoting a culture of giving back to society is demonstrated by the initiative’s success.
Supriya Lifescience Ltd would like to sincerely thank all of the donors, volunteers, and partner blood banks whose combined efforts made the drive run smoothly. The blood will be an essential resource for people in need, underscoring the role that such programs play in closing gaps in healthcare.
About Supriya Lifescience Ltd.:
Established in 1987, Supriya Lifescience Ltd. is a globally recognized manufacturer of active medicinal ingredients. Our state-of-the-art facility is certified by the USFDA, NMPA, EDQM, EUGMP, and Health Canada. Our plant is situated in Khed, District Ratnagiri, while the company’s headquarters are in Mumbai, India. Strong R&D, eight active CEPs, and fourteen active USDMFs support our worldwide compliant facilities (EMA, US FDA, WHO, PMDA, TGA, KFDA, and ANVISA). Our primary business is guided by ethical ideals and EHS regulations. Building intermediates and APIs for innovators and generic companies is the company’s main goal. Additionally, we only work with partners in our role as CMOs.
